Camelid single-domain hcv antibodies and methods of use
AssigneeQoolabs, Inc.
InventorHong QI
Life of this patent
Estimating the term…
Loading patent…
AssigneeQoolabs, Inc.
InventorHong QI
Estimating the term…
The present disclosure in some aspects relates to HCV core antigen polypeptides. In some aspects, the present disclosure further relates to HCV antibodies, including camelid antibodies that specifically bind to HCV core antigen, and antibody fragments. The disclosure further relates to methods of detecting an analyte in a sample using a camelid antibody, such as a camelid VHH antibody or fragments thereof. In one aspect, provided herein is a technology platform for isolating highly specific antibodies and applying these antibodies in an immunoassay, such as a lateral flow immunoassay (LFIA). In some aspects, this technology is used to develop HCV core antigen specific antibodies and to produce LFIA devices for rapid and early diagnosis of HCV. In other aspects, a rapid test is provided for screening and detection of hepatitis C virus infection to improve the diagnosis rate and effectively prevent HCV infection transmission.
A polypeptide comprising:
An isolated camelid antibody that specifically binds to an epitope within an HCV core antigen polypeptide.
A method for detecting an analyte in a sample from a subject, which method comprises:
Dependencies are inferred from the claim text.